Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Cisplatin
×
30 days
×
Clear all
Filters
3
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts
NCT04379596
2026-02-23
DG-03
AstraZeneca
Phase 2
Recruiting
450 enrolled